نتایج جستجو برای: Buccal tablet

تعداد نتایج: 41501  

2015
Chizuko Takigawa Fumio Goto Shigeru Tanda Yasuo Shima Kinomi Yomiya Motohiro Matoba Isamu Adachi Tetsusuke Yoshimoto Kenji Eguchi

OBJECTIVE Rapid analgesic onset opioids, particularly fentanyl buccal tablet, is preferable for managing breakthrough pain. The efficacy and safety of fentanyl buccal tablet and its association with around-the-clock opioids needs to be explored with an option of dose adjustments, more closely reflecting administration in clinical practice. The aim of the study was to assess the safety and effic...

Journal: :Pain medicine 2010
Perry G Fine Arvind Narayana Steven D Passik

BACKGROUND Opioids can be a safe and effective option for carefully selected patients with a structured treatment program that includes consistent monitoring. However, the benefits and risks of opioid therapy for patients with chronic pain, and society as a whole, have been sharply debated. A key component of this debate has involved the administration of rapid-onset opioids for the management ...

2010
Chellan Vijaya Raghavan

Purpose: The objective of the study was to evaluate the naturally available Moringa gum as drug carrier and mucoadhesive component in buccal delivery and to compare the bioavailability of Propranolol Hydrochloride buccal tablet with the oral tablet in healthy human volunteers. Material and Methods: The buccal tablets containing various concentration (Formulation1: 10, F2: 20, F3: 30 and F4: 40 ...

Journal: :iranian journal of pharmaceutical research 0
hoda tayebi school of pharmacy, shahid beheshti university of medical sciences, tehran, iran. seyed alireza mortazavi school of pharmacy, shahid beheshti university of medical sciences, tehran, iran.

orally disintegrating tablets (odts) are capable of turning quickly into a liquid dosage form in contact with the saliva, thus possessing the advantages of both the solid dosage forms particularly stability and liquid dosage forms specially ease of swallowing and pre-gastric absorption of drug. the aim of this study was to prepare a novel matrix-type buccal fast disintegrating ibuprofen tablet ...

Journal: :Pain medicine 2013
Lynn R Webster Kieran A Slevin Arvind Narayana Craig Q Earl Ronghua Yang

OBJECTIVE Evaluate analgesic efficacy, functional benefit, and patient satisfaction with fentanyl buccal tablet vs immediate-release oxycodone for breakthrough pain (BTP). DESIGN Randomized, double-blind, active-controlled crossover trial and 12-week open-label extension. SETTING Forty-two U.S. sites. PATIENTS Opioid-tolerant patients with predominantly chronic noncancer pain experiencing...

2013
Josep Darbà Lisette Kaskens Rainel Sánchez-de la Rosa

BACKGROUND The purpose of this study was to assess the economic impact of the fentanyl buccal tablet for the management of breakthrough cancer pain (BTcP) in Spain. METHODS A 4-year budget impact model was developed for the period 2012-2015 for patients with BTcP from the perspective of the Spanish National Health System. BTcP products included in this model were rapid-onset opioids containin...

2017
Burak Çelik

The aim of this study was to design and optimize risperidone (RIS) mucoadhesive buccal tablets for systemic delivery as an alternative route. Direct compression method was used for the preparation of buccal tablets, and screening studies were conducted with different polymers to determine their effects on tablet characteristics. Carbopol® (CP) and sodium alginate (SA) were selected as two polym...

2009
A. Madgulkar S. Kadam V. Pokharkar

The purpose of the present work was to prepare buccal adhesive tablets of miconazole nitrate. The simplex centroid experimental design was used to arrive at optimum ratio of carbopol 934P, hydroxypropylmethylcellulose K4M and polyvinylpyrollidone, which will provide desired drug release and mucoadhesion. Swelling index, mucoadhesive strength and in vitro drug release of the prepared tablet was ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید